Glen R. Bressner - Board Observer
Glen is a Managing Partner of Originate Ventures (based in Bethlehem, PA), an early stage-oriented venture capital firm that is primarily focused on investing in emerging companies located in Pennsylvania and New Jersey. He has been a Partner with Mid-Atlantic Venture Funds since its founding in 1985 and combined MAVF’s fifth fund to help establish Originate Ventures. Glen began his venture capital career when he joined Key Venture Capital Corporation upon completing his MBA and opened its Boston office in 1984.
Investments that Glen has led include International Quantum Epitaxy (LSE: IQE plc), the world’s leading merchant manufacturer of compound semiconductor wafers, Innovative Solutions & Support, Inc. (NASDAQ: ISSC), a leading provider of flat panel avionics to commercial aircraft, Access Health (NASDAQ: ACCS, acquired by McKesson), a leading provider of health information solutions, Ravisent Technologies (NASDAQ: RSVT), a leader in digital video solutions, AnyTime Access (acquired by Digital Insight), a provider of on-line loan origination and processing solutions, UltraCision (acquired by Johnson & Johnson), developer of the Harmonic Scalpel system, MicroE Systems (acquired by GSI), manufacturer of the most advance position management solutions and CareGain (acquired by Fiserv), a provider of consumer-directed health plan solutions. Glen holds a BSBA, cum laude, from Boston University and an MBA from Babson College.